Top results

homehero.webp

For US Nurse Practitioners

Welcome to NP Psych Navigator, a curated library of clinical tools, educational resources, and inspiring stories from your peers. Our mission is to support your needs as you support your patients with mental illness. 



About Us

Learn more about NP Psych Navigator and our mission to help nurse practitioners improve mental healthcare.

About Us
 

New on NP Psych Navigator

Early vs Delayed Diagnosis: The BP-1 Patient Journey Podcast

Peer Exchange

Early vs Delayed Diagnosis: The BP-1 Patient Journey Podcast

Pradeep Manudhane, MD, and Alan “Tony” Amberg, MSN, APRN, PMHNP-BC, discuss the importance of making an accurate diagnosis of bipolar I disorder (BP-1) and highlight the potential downstream consequences of misdiagnosis.
Bipolar I Disorder Screening in Practice Video

Clinical Insights

Bipolar I Disorder Screening in Practice Video

This Clinical Insights video highlights the challenges in differentiating bipolar I disorder (BP-1) from major depressive disorder (MDD) and outlines how to use measurement-based care tools such as the Rapid Mood Screener to screen for BP-1 in patients previously diagnosed with MDD. 
Partial Agonism: How Is It Thought to Work and What Is the Potential Clinical Relevance?

Quick Guides

Partial Agonism: How Is It Thought to Work and What Is the Potential Clinical Relevance?

Understanding the neurotransmitter mechanisms thought to underlie the effects of medications used in treating mood disorders, including major depressive disorder (MDD), bipolar I disorder (BP-1), and schizophrenia, can help healthcare professionals make informed treatment decisions and manage patients’ symptoms.
Treatment Patterns, Healthcare Resource Utilization, and Costs Associated With the Use of Atypical Antipsychotics as First vs Subsequent Adjunctive Treatment in Major Depressive Disorder

Clinical Article

Treatment Patterns, Healthcare Resource Utilization, and Costs Associated With the Use of Atypical Antipsychotics as First vs Subsequent Adjunctive Treatment in Major Depressive Disorder

This retrospective study by Jain et al aimed to assess the use of atypical antipsychotics as first add-on treatment vs later add-on treatment in patients with MDD and to evaluate the potential impact of atypical antipsychotic line of therapy (LOT) on healthcare resource utilization (HCRU).

Recommended on NP Psych Navigator

Introduction to Bipolar Disorder Video

NP Perspectives

Introduction to Bipolar Disorder Video

Tina Matthews Hayes, DNP, FNP, PMHNP provides an overview of bipolar disorder, including common symptoms and the value of earning your patient’s trust.
Treatment Patterns, Healthcare Resource Utilization, and Costs Associated With the Use of Atypical Antipsychotics as First vs Subsequent Adjunctive Treatment in Major Depressive Disorder

Clinical Article

Treatment Patterns, Healthcare Resource Utilization, and Costs Associated With the Use of Atypical Antipsychotics as First vs Subsequent Adjunctive Treatment in Major Depressive Disorder

This retrospective study by Jain et al aimed to assess the use of atypical antipsychotics as first add-on treatment vs later add-on treatment in patients with MDD and to evaluate the potential impact of atypical antipsychotic line of therapy (LOT) on healthcare resource utilization (HCRU).
SF-12 Health Survey (SF-12v2)

Psychiatric Scales

SF-12 Health Survey (SF-12v2)

The SF-12 Health Survey version 2 is a brief, 12-item questionnaire designed to measure overall physical and mental health status across 8 domains.  
SF-12 Health Survey (SF-12v2)

Psychiatric Scales

SF-12 Health Survey (SF-12v2)

The SF-12 Health Survey version 2 is a brief, 12-item questionnaire designed to measure overall physical and mental health status across 8 domains.  

NP Perspectives

When it comes to giving the best care to your patients, experience matters. Check out our Clinical Insights to hear from our vibrant community of nurse practitioners.

NP Spotlight: Jeremy Schreiber, MSN, PMHNP-BC
NP Spotlight: Jeremy Schreiber, MSN, PMHNP-BC
NP Spotlight: Moushumi Mukerji, MSN, PMHNP-BC, CNM, RN
NP Spotlight: Moushumi Mukerji, MSN, PMHNP-BC, CNM, RN
NP Spotlight: Patricia D. Bursnall, DNP, APRN, FNP-C, PMHNP-BC
NP Spotlight: Patricia D. Bursnall, DNP, APRN, FNP-C, PMHNP-BC
NP Spotlight: Samantha Lau, MSN, FNP-BC, PMHNP-BC
NP Spotlight: Samantha Lau, MSN, FNP-BC, PMHNP-BC

Clinical Tools

SF-12 Health Survey (SF-12v2)

Psychiatric Scales

SF-12 Health Survey (SF-12v2)

The SF-12 Health Survey version 2 is a brief, 12-item questionnaire designed to measure overall physical and mental health status across 8 domains.  
Bipolar I Disorder (BP-1) Treatment Goals: Symptom Remission and Functional Improvement

Educate Your Patient

Bipolar I Disorder (BP-1) Treatment Goals: Symptom Remission and Functional Improvement

Living with bipolar I disorder (BP-1) can mean more than just managing symptoms; it’s about finding balance and working toward getting back to the activities and relationships that matter to you. This guide explores treatment goals that can help you and your care team work toward feeling better and functioning better in daily life. Setting clear goals and focusing on overall improvement can make a real difference in your recovery and long-term well-being.
Treatment Patterns, Healthcare Resource Utilization, and Costs Associated With Use of Atypical Antipsychotics as First vs Subsequent Adjunctive Treatment in Major Depressive Disorder

Quick Guides

Treatment Patterns, Healthcare Resource Utilization, and Costs Associated With Use of Atypical Antipsychotics as First vs Subsequent Adjunctive Treatment in Major Depressive Disorder

Major depressive disorder (MDD) can be associated with substantial emotional, social, and economic burdens. Delaying appropriate treatment may contribute to negative outcomes and increased healthcare use. This quick guide highlights real-world data on the use of atypical antipsychotics as adjunctive therapy, with a focus on treatment patterns and healthcare resource impact in patients with MDD. These insights may help providers consider how treatment sequencing decisions could influence both patient care and system-level outcomes. 
Common Scales in Major Depressive Disorder and Bipolar I Disorder

Quick Guides

Common Scales in Major Depressive Disorder and Bipolar I Disorder

Standardized psychiatric rating scales help healthcare providers gather critical information to support accurate diagnosis and management of mental health conditions, such as major depressive disorder (MDD) and bipolar I disorder (BP-1). When used alongside clinical assessment and patient input, these tools can help monitor treatment response over time and guide clinical decisions as part of measurement-based care.

Clinical Education


Burden of Misdiagnosis in Bipolar I Disorder

Clinical Article

Burden of Misdiagnosis in Bipolar I Disorder

The results of a large, real-world study suggest that misdiagnosis of bipolar I disorder as major depressive disorder can be associated with significantly greater healthcare resource utilization and higher costs, particularly for mental health–related services, highlighting the importance of timely and accurate diagnosis. 
Real-World Treatment Patterns in Bipolar Disorder

Clinical Article

Real-World Treatment Patterns in Bipolar Disorder

The results of a large, real-world study by Jain et al suggest there may be an incongruence between current prescribing patterns and guideline recommendations for bipolar I disorder, with high use of antidepressants and benzodiazepines despite limited recommendations for these agents.
What to Consider When Prescribing Atypical Antipsychotics in Major Depressive Disorder

Test Your Knowledge

What to Consider When Prescribing Atypical Antipsychotics in Major Depressive Disorder

For patients with major depressive disorder (MDD) whose symptoms are not adequately managed with their initial antidepressant, adjunctive atypical antipsychotics can help. Take this quiz to test your knowledge on what providers should consider when prescribing atypical antipsychotics.
Predictors of Treatment-Emergent Affective Switch Quiz

Test Your Knowledge

Predictors of Treatment-Emergent Affective Switch Quiz

Affective switch is a phenomenon that can occur in bipolar I disorder. In particular, affective switch can be triggered by certain medications in what is known as a treatment-emergent affective switch (TEAS), as well as by social and environmental factors. Test your knowledge of the potential symptoms and triggers of affective switch, including TEAS.

Psychiatry Fundamentals

Psychiatry draws upon skills that are essential to the nurse practitioner approach to patient care, empathy, compassion, and understanding. A thorough knowledge of the different mental illnesses complements those skills

Learn more about  psychiatry fundamentals
Psychiatry Fundamentals

Welcome To NP Psych Navigator

This website is intended for healthcare professionals inside the United States.
Please confirm that you are a healthcare professional inside the US.

No, I am not US Healthcare professional

You are now leaving NP Psych Navigator

Links to sites outside of NP Psych Navigator are provided as a resource to the viewer. AbbVie Inc accepts no responsibility for the content of non-AbbVie linked sites.

Redirect to: